Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases

Explore clinical trials studying Eye Diseases. Study availability and eligibility vary by location and protocol.

295 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases trial results

Completed

A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa

NCT00447980

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • University of Califoria, Davis Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Bascom Palmer Eye Insitute Miami, Florida, United States
View Trial Details
Completed

A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration

NCT00447954

Conditions
Eye Diseases, Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage, Retinal Diseases
Locations
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Retina Group of Florida Hollywood, Florida, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • Ophthalmic Consultants of Boston Boston, Massachusetts, United States
View Trial Details
Completed

Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia

NCT06045299

Conditions
Eye Diseases, Miosis, Myopia, +8 more
Locations
  • Eye Hospital, Wenzhou Medical University Wenzhou, Zhejiang, China
  • Beijing Tongren Hospital, Capital Medical University Beijing, China
  • Peking University First Hospital Beijing, China
  • The Second Xiangya Hospital of Central South University Changsha, China
View all 19 locations
View Trial Details
Completed

Investigation of the Safety and Effectiveness of a Trifocal IOL

NCT04176965

Conditions
Aphakia, Aphakia, Postcataract, Cataract, +4 more
Locations
  • Mitchell C Shultz MD/Shultz Chang Vision Northridge, California, United States
  • Coastal Vision Medical Group Orange, California, United States
  • Arbor Centers for Eye Care Orland Park, Illinois, United States
  • Michael Washburn Center for Ophthalmic Research Indianapolis, Indiana, United States
View all 20 locations
View Trial Details
Completed

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

NCT01868997

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Jules Stein Eye Institute at UCLA Los Angeles, California, United States
  • University of Denver Aurora, Colorado, United States
  • Emory University Department of Ophthalmology Atlanta, Georgia, United States
  • University of Iowa Hospitals and Clinics, Department of Ophthalmology Iowa City, Iowa, United States
View all 15 locations
View Trial Details

Related conditions